Emergent Biosolutions (NYSE: EBS) as signed a license agreement with VaxInnate Corporation under which Emergent acquired the exclusive right to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE